|
1
|
Hassan M, El-Hefnawy AS, Elshal AM, Mosbah
A, El-Baz M and Shaaban A: Renal epithelioid angiomyolipoma: A rare
variant with unusual behavior. Int Urol Nephrol. 46:317–322. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Koo KC, Kim WT, Ham WS, Lee JS, Ju HJ and
Choi YD: Trends of presentation and clinical outcome of treated
renal angiomyolipoma. Yonsei Med J. 51:728–734. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lane BR, Aydin H, Danforth TL, Zhou M,
Remer EM, Novick AC and Campbell SC: Clinical correlates of renal
angiomyolipoma subtypes in 209 patients: Classic, fat poor,
tuberous sclerosis associated and epithelioid. J Urol. 180:836–843.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rakowski SK, Winterkorn EB, Paul E, Steele
DJ, Halpern EF and Thiele EA: Renal manifestations of tuberous
sclerosis complex: Incidence, prognosis, and predictive factors.
Kidney Int. 70:1777–1782. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eble JN, Sauter G, Epstein J and
Sesterhenn IA: World Health Organization Classification of
TumoursPathology and Genetics of Tumours of the Urinary System and
Male Genital Organs. IARC Press; Lyon: pp. 65–69. 2004
|
|
6
|
Mai KT, Perkins DG and Collins JP:
Epithelioid cell variant of renal angiomyolipoma. Histopathology.
28:277–280. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brimo F, Robinson B, Guo C, Zhou M, Latour
M and Epstein JI: Renal epithelioid angiomyolipoma with atypia: A
series of 40 cases with emphasis on clinicopathologic prognostic
indicators of malignancy. Am J Surg Pathol. 34:715–722.
2010.PubMed/NCBI
|
|
8
|
Nese N, Martignoni G, Fletcher CD, Gupta
R, Pan CC, Kim H, Ro JY, Hwang IS, Sato K, Bonetti F, et al: Pure
epithelioid PEComas (so-called epithelioid angiomyolipoma) of the
kidney: A clinicopathologic study of 41 cases: Detailed assessment
of morphology and risk stratification. Am J Surg Pathol.
35:161–176. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Srigley JR, Delahunt B, Eble JN, Egevad L,
Epstein JI, Grignon D, Hes O, Moch H, Montironi R, Tickoo SK, et
al: The international society of urological pathology (ISUP)
vancouver classification of renal neoplasia. Am J Surg Pathol.
37:1469–1489. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martignoni G, Pea M, Rigaud G, Manfrin E,
Colato C, Zamboni G, Scarpa A, Tardanico R, Roncalli M and Bonetti
F: Renal angiomyolipoma with epithelioid sarcomatous transformation
and metastases: Demonstration of the same genetic defects in the
primary and metastatic lesions. Am J Surg Pathol. 24:889–894. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sato K, Ueda Y, Tachibana H, Miyazawa K,
Chikazawa I, Kaji S, Nojima T and Katsuda S: Malignant epithelioid
angiomyolipoma of the kidney in a patient with tuberous sclerosis:
An autopsy case report with p53 gene mutation analysis. Pathol Res
Pract. 204:771–777. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bing Z, Yao Y, Pasha T, Tomaszewski JE and
Zhang PJ: p53 in pure epithelioid PEComa: An immunohistochemistry
study and gene mutation analysis. Int J Surg Pathol. 20:115–122.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Zhu M and Wang YL: Malignant
epithelioid angiomyoliopoma of the kidney with pulmonary metastases
and p53 gene mutation. World J Surg Oncol. 10:2132012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li W, Guo L, Bi X, Ma J and Zheng S:
Immunohistochemistry of p53 and Ki-67 and p53 mutation analysis in
renal epithelioid angiomyolipoma. Int J Clin Exp Pathol.
8:9446–9451. 2015.PubMed/NCBI
|
|
15
|
Ooi SM, Vivian JB and Cohen RJ: The use of
the Ki-67 marker in the pathological diagnosis of the epithelioid
variant of renal angiomyolipoma. Int Urol Nephrol. 41:559–565.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barnes EA, Kenerson HL, Jiang X and Yeung
RS: Tuberin regulates E-cadherin localization: Implications in
epithelial-mesenchymal transition. Am J Pathol. 177:1765–1778.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Z, Gong Q and Fan Q: Expression of
E-cadherin in angiomyolipoma. Hum Pathol. 43:2348–2353. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Konosu-Fukaya S, Nakamura Y, Fujishima F,
Kasajima A, McNamara KM, Takahashi Y, Joh K, Saito H, Ioritani N,
Ikeda Y, et al: Renal epithelioid angiomyolipoma with malignant
features: Histological evaluation and novel immunohistochemical
findings. Pathol Int. 64:133–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Alì G, Boldrini L, Capodanno A,
Pelliccioni S, Servadio A, Crisman G, Picchi A, Davini F, Mussi A
and Fontanini G: Expression of p-AKT and p-mTOR in a large series
of bronchopulmonary neuroendocrine tumors. Exp Ther Med. 2:787–792.
2011.PubMed/NCBI
|
|
23
|
Li N, Zhong M and Song M: Expression of
phosphorylated mTOR and its regulatory protein is related to
biological behaviors of ameloblastoma. Int J Clin Exp Pathol.
5:660–667. 2012.PubMed/NCBI
|
|
24
|
Zheng S, Bi XG, Song QK, Yuan Z, Guo L,
Zhang H and Ma JH: A suggestion for pathological grossing and
reporting based on prognostic indicators of malignancies from a
pooled analysis of renal epithelioid angiomyolipoma. Int Urol
Nephrol. 47:1643–1651. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lecuit T and Yap AS: E-cadherin junctions
as active mechanical integrators in tissue dynamics. Nat Cell Biol.
17:533–539. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takeichi M: Dynamic contacts: Rearranging
adherens junctions to drive epithelial remodelling. Nat Rev Mol
Cell Biol. 15:397–410. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gallin WJ, Edelman GM and Cunningham BA:
Characterization of L-CAM, a major cell adhesion molecule from
embryonic liver cells. Proc Natl Acad Sci USA. 80:pp. 1038–1042.
1983; View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schuh R, Vestweber D, Riede I, Ringwald M,
Rosenberg UB, Jäckle H and Kemler R: Molecular cloning of the mouse
cell adhesion molecule uvomorulin: cDNA contains a B1-related
sequence. Proc Natl Acad Sci USA. 83:pp. 1364–1368. 1986;
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ogou SI, Yoshida-Noro C and Takeichi M:
Calcium-dependent cell-cell adhesion molecules common to
hepatocytes and teratocarcinoma stem cells. J Cell Biol.
97:944–948. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yoshida-Noro C, Suzuki N and Takeichi M:
Molecular nature of the calcium-dependent cell-cell adhesion system
in mouse teratocarcinoma and embryonic cells studied with a
monoclonal antibody. Dev Biol. 101:19–27. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mertz AF, Che Y, Banerjee S, Goldstein JM,
Rosowski KA, Revilla SF, Niessen CM, Marchetti MC, Dufresne ER and
Horsley V: Cadherin-based intercellular adhesions organize
epithelial cell-matrix traction forces. Proc Natl Acad Sci USA.
110:pp. 842–847. 2013; View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ghahhari NM and Babashah S: Interplay
between microRNAs and WNT/β-catenin signalling pathway regulates
epithelial-mesenchymal transition in cancer. Eur J Cancer.
51:1638–1649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bhatt T, Rizvi A, Batta SP, Kataria S and
Jamora C: Signaling and mechanical roles of E-cadherin. Cell Commun
Adhes. 20:189–199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kobayashi N, Matsuzaki O, Shirai S, Aoki
I, Yao M and Nagashima Y: Collecting duct carcinoma of the kidney:
An immunohistochemical evaluation of the use of antibodies for
differential diagnosis. Hum Pathol. 39:1350–1359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Muramaki M, Miyake H, Terakawa T, Kusuda Y
and Fujisawa M: Expression profile of E-cadherin and N-cadherin in
urothelial carcinoma of the upper urinary tract is associated with
disease recurrence in patients undergoing nephroureterectomy.
Urology. 78:1443.e7–e12. 2011. View Article : Google Scholar
|
|
36
|
Wang N, He YL, Pang LJ, Zou H, Liu CX,
Zhao J, Hu JM, Zhang WJ, Qi Y and Li F: Down-regulated E-cadherin
expression is associated with poor five-year overall survival in
bone and soft tissue sarcoma: Results of a meta-analysis. PLoS One.
10:e01214482015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yoo J, Park S, Kang CS, Kang SJ and Kim
BK: Expression of E-cadherin and p53 proteins in human soft tissue
sarcomas. Arch Pathol Lab Med. 126:33–38. 2002.PubMed/NCBI
|
|
38
|
Martignoni G, Pea M, Reghellin D, Zamboni
G and Bonetti F: PEComas: The past, the present and the future.
Virchows Arch. 452:119–132. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang J, Du X, Wang G, Sun Y, Chen K, Zhu
X, Lazar AJ, Hunt KK, Pollock RE and Zhang W: Mesenchymal to
epithelial transition in sarcomas. Eur J Cancer. 50:593–601. 2014.
View Article : Google Scholar : PubMed/NCBI
|
